A Registry for Participants With Chronic Hypoparathyroidism
Completed · NCT01922440
Conditions: Hypoparathyroidism
At a glance
- Research payments reported, 2025
- $143,851
- U.S. investigators named
- 28
- Sites paid
- 27
- Planned or actual enrollment
- 1,339
About the trial
- Sponsor
- Takeda (with Takeda Development Center Americas, Inc.)
- Tested
- No intervention (other)
- Dates
- Started 2013-07-30; completion 2026-06-30
- Results posted
- Not yet
The main aim of this study is to find out the long-term safety and effectiveness profile of recombinant human parathyroid hormone (1-84) (rhPTH\[1-84\]) treatment in participants with chronic hypoparathyroidism under conditions of routine clinical practice. Participants will be treated according to their clinic's standard practice determined by the treating doctors. Each participant will fill out a study questionnaire during a routine doctor visit.
From ClinicalTrials.gov, last updated 2026-07-14. Full record, eligibility and contacts (opens in a new tab)
Industry funding
Takeda Pharmaceuticals U.S.A., Inc. reported $143,851 in research payments for this study in 2025 (169 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Amy Warriner Endocrinology & Diabetes · Birmingham, AL
- Anna Ryabets-lienhard, D.O. Emergency Medicine · Los Angeles, CA
- Wendy Sacks, M.D. Endocrinology & Diabetes · Los Angeles, CA
- Thomas O. Carpenter, MD Pediatric Endocrinology · New Haven, CT
- Pauline Camacho, MD Endocrinology & Diabetes · Maywood, IL
- Stuart M. Sprague, DO Nephrology (Kidney) · Evanston, IL
- Sharon H. Chou, MD Endocrinology & Diabetes · Boston, MA
- Michael Mannstadt, MD Internal Medicine · Boston, MA
- Paul A. Sack, M.D. Endocrinology & Diabetes · Baltimore, MD
- Robert P. Zitsch III, M.D. ENT (Otolaryngology) · Columbia, MO
- Claire Baker, M.D. Endocrinology & Diabetes · Omaha, NE
- Sara E. Lubitz, M.D. Endocrinology & Diabetes · New Brunswick, NJ
- Ian Marshall, MD Pediatric Endocrinology · New Brunswick, NJ
- Lisa G. Abbott, MD Endocrinology & Diabetes · Reno, NV
- Samer Nakhle, MD Endocrinology & Diabetes · Las Vegas, NV
- Robert S. Busch, M.D. Endocrinology & Diabetes · Albany, NY
- Natalie Cusano, M.D. Endocrinology & Diabetes · New York, NY
- Michael H. Shanik, M.D. Endocrinology & Diabetes · Smithtown, NY
- Steven W. Ing, MD Endocrinology & Diabetes · Columbus, OH
- Michelle A. Kovalaske, M.D. Endocrinology & Diabetes · Columbus, OH
- Intekhab Ahmed, M.D. Endocrinology & Diabetes · Philadelphia, PA
- Michael A. Levine, MD Pediatric Endocrinology · Philadelphia, PA
- Mushtaq A. Syed, MD Endocrinology & Diabetes · Indiana, PA
- Chris Bajaj, D.O. Endocrinology & Diabetes · Fort Worth, TX
- Valerie D. Espinosa, M.D. Endocrinology & Diabetes · Austin, TX
- Steve V. Fordan, MD Endocrinology & Diabetes · Dallas, TX
- Anjanette Tan, M.D. Endocrinology & Diabetes · Fort Worth, TX
- Jennifer J. Kelly, DO Endocrinology & Diabetes · South Burlington, VT
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Massachusetts General Hospital, MA $22,200
- The Feinstein Institutes for Medical Research $21,075
- Endocrine Associates of Long Island PC $10,566
- Northern Nevada Endocrinology $10,200
- $10,100
- Arthur G James Cancer Hospital $10,075
- Indiana-Armstrong Endocrinology Associates $7,900
- University Behavioral Health Care, NJ $6,255
- Children's Hosp of Los Angeles, CA $5,304
- Children's Hospital of Philadelphia, PA $5,192
- Northshore University Healthsystem - Evanston Hospital, IL $4,200
- Thomas Jefferson University Hospital, PA $3,750
- Diabetes & Thyroid Center of Fort Worth PLLC $3,710
- Riverside Methodist Hospital, OH $3,450
- Brigham and Women's Hospital, MA $2,912
- Cedars-Sinai Medical Center, CA $2,730
- Palm Research Center Inc $2,520
- Thyroid Endocrinology and Diabetes PA $2,100
- Loyola University Medical Center, IL $1,814
- The Nebraska Methodist Hospital, NE $1,328
- Yale University $1,325
- Univ. of Vermont - Fletcher Allen Health Care, VT $1,000
- Texas Diabetes and Endocrinology PA $900
- Albany Medical Center Hospital, NY $870
- University of Missouri Health Care, MO $795
- Medstar Health Research Institute Inc $750
- University of Alabama Hospital, AL $530
- Texas Diabetes & Endocrinology PA $300
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.